TRCT
TMCI icon

Tower Research Capital (TRC)’s Treace Medical Concepts TMCI Stock Holding History

Tower Research Capital (TRC)’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.9K Sell
9,763
-6,670
-41% -$18.3K ﹤0.01% 2946
2026
Q1 		$22K Buy
16,433
+8,374
+104% +$16.7K ﹤0.01% 3414
2025
Q4 		$19.7K Buy
8,059
+5,974
+287% +$25.9K ﹤0.01% 3106
2025
Q3 		$14K Sell
2,085
-3,415
-62% -$22.3K ﹤0.01% 3635
2025
Q2 		$32.3K Buy
5,500
+4,490
+445% +$29.3K ﹤0.01% 3343
2025
Q1 		$8.47K Sell
1,010
-796
-44% -$7.15K ﹤0.01% 3888
2024
Q4 		$13.4K Sell
1,806
-4,261
-70% -$28.5K ﹤0.01% 3528
2024
Q3 		$35.2K Buy
6,067
+211
+4% +$1.35K ﹤0.01% 2922
2024
Q2 		$38.9K Buy
5,856
+5,613
+2,310% +$45.3K ﹤0.01% 3289
2024
Q1 		$3.17K Sell
243
-9,303
-97% -$124K ﹤0.01% 4911
2023
Q4 		$122K Buy
9,546
+5,465
+134% +$55.2K ﹤0.01% 2494
2023
Q3 		$53.5K Buy
4,081
+2,296
+129% +$42K ﹤0.01% 2493
2023
Q2 		$45.7K Buy
1,785
+752
+73% +$19.4K ﹤0.01% 2657
2023
Q1 		$26K Sell
1,033
-3,020
-75% -$70.9K ﹤0.01% 3172
2022
Q4 		$94K Sell
4,053
-1,310
-24% -$30.2K ﹤0.01% 1895
2022
Q3 		$118K Buy
5,363
+1,397
+35% +$27K ﹤0.01% 2432
2022
Q2 		$57K Buy
3,966
+2,558
+182% +$43.1K ﹤0.01% 2763
2022
Q1 		$27K Buy
1,408
+662
+89% +$12.9K ﹤0.01% 3261
2021
Q4 		$14K Buy
746
+413
+124% +$8.52K ﹤0.01% 4108
2021
Q3 		$9K Buy
333
+245
+278% +$6.74K ﹤0.01% 4468
2021
Q2 		$3K Buy
+88
New +$2.8K ﹤0.01% 4961

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Tower Research Capital (TRC)'s TMCI Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Treace Medical Concepts (TMCI) stake by 41% in Q2 2026, selling an estimated $18.3K and leaving 9,763 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Tower Research Capital (TRC) first reported a position in TMCI in Q2 2021 and has held it in 21 quarters since. The position peaked at $122K in Q4 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Tower Research Capital (TRC) held 9,763 shares of Treace Medical Concepts worth $38.9K as of Q2 2026.
  • Tower Research Capital (TRC) sold 6,670 Treace Medical Concepts shares in Q2 2026, an estimated $18.3K.
  • Treace Medical Concepts made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2946 holding.
  • Tower Research Capital (TRC) first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s Treace Medical Concepts position peaked at $122K in Q4 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.